HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neurovascular and molecular mechanisms in migraine headaches.

Abstract
This chapter reviews the evidence that challenges traditional and unproven notions which perpetuate the singular importance of constriction and dilation to the genesis of migraine pain. New data in experimental laboratory models suggest that migraine headache may develop primarily from metabolic/neurophysiological events (as yet unidentified) within the cortical mantle, or from a disturbance in those regions of brain which closely approximate the distribution of trigeminovascular fibers innervating meningeal blood vessels. Accordingly, this chapter will review the consequences of trigeminovascular activation to pain and meningeal inflammation, and will summarize emerging molecular and pharmacological data suggesting that ergot alkaloids and sumatriptan alleviate pain primarily via activation of pre-junctional 5-HT1 heteroreceptors residing on primary afferent trigeminovascular fibers.
AuthorsM A Moskowitz, R Macfarlane
JournalCerebrovascular and brain metabolism reviews (Cerebrovasc Brain Metab Rev) Vol. 5 Issue 3 Pg. 159-77 ( 1993) ISSN: 1040-8827 [Print] United States
PMID8217498 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
Topics
  • Animals
  • Brain Chemistry (physiology)
  • Cerebrovascular Circulation (physiology)
  • Humans
  • Meninges (physiopathology)
  • Migraine Disorders (drug therapy, metabolism, physiopathology)
  • Trigeminal Nerve (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: